Skip to content Skip to menu Skip to footer

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs approximately 40,700 employees in 75 countries, and markets its products in more than 180 countries.

Novo Nordisk’s B shares are listed on NASDAQ Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange

the story of Novo Nordisk goes back more than 80 years. It began when August Krogh, a Nobel Prize-winning professor at the University of Copenhagen, decided he wanted to start producing a revolutionary new medical preparation called insulin.

Dettagli dell’organizzazione

Event participation(s)

Passato
Partecipazione: In loco